Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 12, 2023

BUY
$19.2 - $24.47 $16.1 Million - $20.6 Million
840,000 New
840,000 $18.2 Million
Q4 2021

Feb 08, 2022

BUY
$17.1 - $23.34 $9.92 Million - $13.5 Million
580,000 Added 1160.0%
630,000 $12.5 Million
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $984,000 - $1.13 Million
50,000 New
50,000 $984,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.18B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.